Fidelity International
NXTM

Fidelity International’s NxStage Medical Inc. NXTM Stock Holding History

Fidelity International’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-148,452
Closed -$3.72M – 534
2017
Q2 		$3.72M Hold
148,452
– – 0.01% 411
2017
Q1 		$3.98M Buy
+148,452
New +$4.1M 0.01% 422

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity International's NXTM Position: Q3 2017 in Review

Fidelity International sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 148,452 shares — an estimated $3.72M sold.

Fidelity International first reported a position in NXTM in Q1 2017 and held it in 2 quarters. The position peaked at $3.98M in Q1 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Fidelity International reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Fidelity International sold 148,452 NxStage Medical Inc. shares in Q3 2017, an estimated $3.72M.
  • Fidelity International first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 2 quarters.
  • Fidelity International's NxStage Medical Inc. position peaked at $3.98M in Q1 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Fidelity International's 13F filing for Q3 2017, filed 13 Nov 2017.